JPML Denies Efforts to Create Centralized Docket for Cases Relating to Benzene Content in Acne Treatment Products



DOCUMENTS
  • Order


WASHINGTON, D.C. –– The U.S. Judicial Panel on Multidistrict Litigation has denied efforts to create a centralized docket for cases relating to the benzene content in acne treatment products, concluding that a “number of considerations weigh against centralization.”

In the Aug. 1 order, the JPML pointed out that all but one of the lawsuits are pending against an individual defendant and involve a single product line.

“Plaintiffs here do not allege an industry-wide conspiracy or an indivisible physical injury caused by multiple defendants’ products or conduct,” the JPML wrote. “Nor is this a situation where all parties support centralization.”

The …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Depo-Provera CI Litigation

November 04, 2024

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS